TransMedics (TMDX) Group announced the signing of a long-term lease for its new global headquarters at Assembly Innovation Park in Somerville, as well as the acquisition of the adjacent land parcel to create an integrated TransMedics campus environment. This strategic expansion reflects the company’s commitment to accelerating the next wave of transplant innovations, growth, and the transformation of global organ transplant therapy. The new headquarters will support TransMedics’ operational expansion, bringing together corporate, research, development, and advanced manufacturing capabilities in a purpose-built, state-of-the-art facility. TransMedics plans to relocate on or before January 2028. The move is expected to significantly enhance the company’s ability to attract and retain top talent to fuel scaling the organization globally.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- TransMedics: Scaling Organ Care and Aviation Logistics Amid Accelerating U.S. Transplant Volumes Supports Buy Rating
- TransMedics Group: Sustained Procedure Volumes and Margin Upside Support Buy Rating
- Piper believes Street service revenue target for TransMedics looks achievable
- TransMedics Group: Strong Q4 Transplant Volume Momentum and Revenue Upside Support Buy Rating
- TransMedics price target raised to $148 from $147 at Canaccord
